On February 28, 2011, The Honorable Leonard P. Stark issued the Court’s Markman Opinion in Pfizer Inc., et al. v. Dr. Reddy’s Laboratories Ltd., et al., Civil Action No. 09-943-LPS (D.Del.), construing the disputed terms of the patent-in-suit, U.S. Patent No. 5,969,156 and its Reexamination Certificate (collectively, "the ‘156 patent"). The patent-in-suit relates to novel crystalline forms of atorvastatin.
Complete copies of the Court’s Memorandum Opinion and Order setting forth its construction of the disputed terms are attached.